"First Antiviral Drug in Glycovirology"BOSTON, MASSACHUSETTS - September 6, 2023 - BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical stage biotechnology company developing oral drugs to treat COVID-19 and
BOSTON, MASSACHUSETTS, Aug. 08, 2023 (GLOBE NEWSWIRE) BIOXYTRAN, INC. (BIXT), (the "Company"), a clinical stage biotechnology company developing oral drugs to treat COVID-19 and other viral diseases, announced the